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Background: The epidemiology of dengue in the South Pacific has been characterized by transmission of a single
dominant serotype for 3–5 years, with subsequent replacement by another serotype. From 2001 to 2008 only
DENV-1 was reported in the Pacific. In 2008, DENV-4 emerged and quickly displaced DENV-1 in the Pacific, except in
New Caledonia (NC) where DENV-1 and DENV-4 co-circulated in 2008–2009. During 2012–2013, another DENV-1
outbreak occurred in NC, the third DENV-1 outbreak in a decade. Given that dengue is a serotype-specific
immunizing infection, the recurrent outbreaks of a single serotype within a 10-year period was unexpected.
Findings: This study aimed to inform this phenomenon by examining the phylogenetic characteristics of the
DENV-1 viruses in NC and other Pacific islands between 2001 and 2013. As a result, we have demonstrated that NC
experienced introductions of viruses from both the Pacific (genotype IV) and South-east Asia (genotype I). Moreover,
whereas genotype IV and I were co-circulating at the beginning of 2012, we observed that from the second half of
2012, i.e. during the major DENV-1 outbreak, all analyzed viruses were genotype I suggesting that a genotype
switch occurred.
Conclusions: Repeated outbreaks of the same dengue serotype, as observed in NC, is uncommon in the Pacific
islands. Why the earlier DENV-1 outbreaks did not induce sufficient herd immunity is unclear, and likely multifactorial,
but the robust vector control program may have played a role by limiting transmission and thus maintaining a large
susceptible pool in the population.
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Dengue is the most prevalent arthropod-borne viral infec-
tion of humans in tropical and subtropical countries.
Every year, dengue virus (DENV) infections cause more
than 50 million cases, 500 000 hospitalizations and 12 500
deaths in the world [1,2]. DENV is a single-stranded,
positive-sense RNA virus of the genus Flavivirus transmit-
ted by Aedes mosquitoes. There are four distinct serotypes
(DENV-1 to DENV-4) and infection with one does not
provide long-term cross-protective immunity against the* Correspondence: mdupont@pasteur.nc
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article, unless otherwise stated.three others [3,4]. Based on the sequence of the envelope
gene (E), each serotype may be divided into distinct geno-
types often associated with specific geographical regions.
Both epidemiological observations and in vitro studies
suggest that distinct genotypes have different potential to
cause severe dengue epidemics [5-7]. Thus, molecular epi-
demiologic studies have become a critical issue for under-
standing epidemic patterns of viral spread.
In the Pacific, dengue epidemics were mainly caused by a
single serotype/genotype introduced from a hyper-endemic
continental country. In individual Pacific Islands Countries
and Territories (PICTs) the epidemiology of dengue is
heterogeneous. Small PICTs sustain DENV transmission
for only several months, while larger ones, like Frenched Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Dengue epidemic profile in New Caledonia from 2001 to 2013. The number of dengue cases represents the confirmed and
probable cases. This Figure presents the succession of epidemic years (2003–2004, 2008–2009 and 2012–2013) and non-epidemic years in NC. It
also highlights the seasonality of DENV epidemics in NC (peak in March or April).
Dupont-Rouzeyrol et al. Virology Journal 2014, 11:61 Page 2 of 6
http://www.virologyj.com/content/11/1/61Polynesia (PF) or New Caledonia (NC), may experience
active circulation of a single serotype/genotype for
several years until the emergence of a new epidemic
viral strain [8-10]. In this study, we reconstruct the
epidemiological and phylogenetic history of DENV-1 in
NC during the last decade to better understand the NC
dengue epidemiology.
In NC dengue epidemics have a 3–4 years cyclical pat-
tern of occurrence [11] with dengue outbreaks usually
lasting two years, with two peaks occurring during the
two consecutive hot-and-rainy seasons and few cases re-
ported during the cool season in-between (Figure 1). InTable 1 New Caledonia dengue epidemiological data from th
Year Diagnostic demands Confirmed cases Probable cases
2001 956 21 0
2002 1111 64 33
2003 7758 601 1997
2004 2563 179 281
2005 760 2 43
2006 904 9 44
2007 1012 33 6
2008 5262 1008 123
2009 14927 6328 968
2010 1841 25 67
2011 3567 2 10
2012 3986 654 54
2013 22375 8545 1380
The number of tests requests, confirmed cases (RT-PCR and/or NS1), probable cases
aImported cases among the confirmed cases, bRecorded by the Health Department2001, as DENV-1 was emerging in several PICTs [9,11],
imported dengue cases from PF were reported in NC.
The following year, about 100 DENV-1 local cases were
detected, announcing the large DENV-1 outbreak that
hit the territory in 2003–2004 (Table 1) [11-13]. In 2007,
after two years without any report of locally acquired
DENV infections, DENV-1 cases were reported (Table 1).
Half of them were imported cases from PF where a
DENV-1 epidemic was still ongoing [14]. In November
2008, while DENV-1 transmission was still active, DENV-
4 was detected in people coming back from Vanuatu
where the serotype had recently emerged [10,15,16].e years 2001 to 2013
Imported casesa,b Main DENV serotype Number of deathsb
21 1 0
10 1 0
nd 1 17
nd 1 2
2 1 0
8 1 0
19 1 0
12 1 and 4 2
13 1 and 4 3
1 1 0
2 - 0
3 1 1
33 1 4
(IgM only) and deaths probably linked to dengue are reported.
of New Caledonia, nd not determined.
Figure 2 (See legend on next page.)
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Figure 2 Evolutionary relationships of E gene sequences of DENV-1 (1478 nt). Maximum-Likelihood original trees derived from 110 DENV-1
E gene sequences (90 PICTs and 20 retrieved from GenBank). The percentage of replicate trees in which the associated taxa clustered together in
the bootstrap test (1000 replicates) is shown for values over 80. The period (years) these strains have been collected is indicated just after the
country isocode. The number in brackets represents the number of NC DENV-1 strains identical (nucleotide sequence) to the strain reported on
the tree. The 73 (53 + 20 in brackets) NC DENV-1 strains are shown in bold. Genbank accession numbers of the DENV-1 E gene sequenced for this
study are reported in Additional file 1.
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more than 25 years [17]. Despite an active surveillance,
NC health authorities did not reach to prevent and control
the introduction of DENV-4. In 2009, NC experienced an
epidemic concomitantly involving DENV-1 and DENV-4
(Table 1) [13]. In 2010, no more DENV-4 cases were re-
ported while DENV-1 continued to be detected until the
end of year. The serotype switch observed in other PICTs
did not occur in NC [10,16]. In 2011, no dengue cases
were detected although the number of dengue suspected
cases had dramatically increased due to the occurrence of
the first chikungunya epidemic ever reported in NC
[18,19]. Unexpectedly, DENV-1 re-emerged in 2012–2013
in NC and caused the largest outbreak ever reported
(Figure 1 and Table 1) [13]. This outbreak was particularly
severe: rapid increase of the number of cases, high rate of
hospitalization in a short time, important transmission
during the cool season, restart of active transmission early
after the cool season.
In this study, envelope (E) genes from 90 DENV-1 vi-
ruses recovered in NC and other PICTs (Additional file 1)
were amplified by RT-PCR and sequenced as described
previously [16]. As DENV-1 is divided in five genotypes
[5], manually designed oligonucleotide primers D1M/869F
(5’-GGAACATCCATCACCCAGAA-3’) and D1NS1/2510R
(5’-CTCTGTCCAGGTGTGAACTT-3’) were used for both
amplification and sequencing of genotype IV viruses, add-
itional primers D1E/1352F (5’-GTGATCGTTACTGTCCA
CAC-3’) and D1E/OOCF (5’- GTAATAGTCACCGTCCA
CAC-3’) were used to sequence genotype IV and I viruses
respectively. Overlapping fragments were assembled with
Staden Package (MRC Cambridge, England). Nucleotide
sequences were aligned with the multiple sequence align-
ment software Clustal W integrated in MEGA version 5.0
software. Phylogenetic analysis was then carried out with
MEGA5, using the Maximum likelihood method. The
evolutionary distances were computed using the Kimura
2-parameter method defined as one of the best evolution
model with MEGA5. As shown by the Figure 2, NC
strains collected from 2001 to 2013 belong to genotypes I
and IV. All sequenced genotype IV viruses recovered in
NC during the last decade group together with other
DENV-1 strains collected in PICTs during the same
period within the “Pacific clade” previously described [9].
DENV-1/genotype IV viruses recovered in NC from 2002
to 2004 and from 2007 to 2012 are close to strains isolatedin PF in 2001–2002 and in 2006–2007 respectively. This
observation corroborates epidemiological data that sug-
gested that the first two dengue outbreaks of the decade
in NC resulted from introduction of DENV-1 viruses from
PF. Interestingly, NC genotype IV viruses recovered in
2012 are closely related to DENV-1 strains collected in
Fiji, Kiribati and Niue within the same year. Based on our
findings, the re-emergence of DENV-1 genotype IV in NC
in 2012 may have resulted from introductions of viruses
from other PICTs. Genotype I viruses recovered in NC
form two clearly independent clusters, the first cluster in-
cludes strains collected in 2002–2003 as mentioned before
[8,20], the second cluster contains viruses isolated in NC
in 2012–2013. This later cluster is close to a strain recov-
ered in Vietnam in 2011 (VN11/JXD93687) what suggests
that the re-emergence of DENV-1 genotype I in NC in
2012 resulted from a new introduction of a virus from
South-east Asia. Moreover, the amino acids analysis
showed that all NC 2012–2013 DENV-1/genotype I
strains share 100% homology with the VN11/JXD93687
and VN08/GU131812 strains (data not shown). From
February to July 2012, DENV-1 viruses recovered in
NC belonged to either genotype I or IV. From August
2012 to the end of 2013, all the NC DENV-1 strains se-
quenced were genotype I (Figure 2). Moreover all DENV-1
positive sera collected in August 2012 and in August 2013
were all amplified by genotype I specific RT-PCR using the
primers D1E/MDRF (5’- GAAATATTCAGTAATAGTCA
CCGT-3’) and D1EREV-R (5’- CATGGTGCATCTGTT
CC-3’) (data not shown). These data are suggesting that
a switch occurred in the genotype circulating as observed
in hyperendemic countries [21].
The occurrence of two consecutive outbreaks due to
the same dengue serotype had historically already been
observed in NC and other PICTs [7,11]. Thus, the re-
emergence of DENV-1 in NC in 2008, i.e. five years after
the previous DENV-1 outbreak, was not surprising, par-
ticularly given the active circulation of the virus in PF.
However, what was unexpected was the fact that DENV-1
was not replaced by DENV-4 during the 2008–2009 out-
break and that both serotype circulated during more than
a year. The absence of serotype replacement contrasts
with the historical data on the epidemiology of dengue in
PICTs and with the situation reported during the same
period in other PICTs [10,15]. Otherwise in contrast with
the NC historical dengue epidemiological profile [11]
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had already circulated in the country for ten years. As
suggested by our phylogenetic analyses the recurrent
re-emergences of DENV-1 over the last decade in NC
mainly resulted from introductions of “Pacific clade”
genotype IV viruses from other PICTs, particularly PF.
In addition introduction of South-east Asian genotype
I viruses also contributed to the circulation of DENV-1
in NC, at least transiently in 2002–2003 [8,20] and
sustainably in 2012–2013. The fact that introductions
events led to sustainable circulation of DENV-1 and
the occurrence of three consecutive outbreaks suggests
that, at least until 2013, the NC population did not
already had acquired sufficient herd immunity against
DENV-1. The observation that NC experienced strong
positive human migratory threshold during the past
5 years suggest that the pool of susceptible hosts may
have been resupplied by new residents [22]. Another
factor that could have contributed to maintain the pool
of susceptible hosts is the limitation of DENV-1 infection
rates during the 2008–2009 outbreak, due to transient
cross-protective immunity provided by the co-circulation
of DENV-4 [23]. An alternative factor that might have
contributed to maintain the proportion of susceptible
hosts to a level compatible with sustained DENV-1 trans-
mission is the vector control pressure. For several years,
NC Health Authorities have invested lots of efforts in
maintaining efficient vector control. Combined to the NC
standard of living (air conditioning…) and to climate con-
ditions less favorable to DENV transmission during the
cool season, vector control measures might have contrib-
uted to modify dengue epidemiological profile. An add-
itional factor that could have contributed to sustainable
transmission of DENV-1 in NC in 2012–2013 is the emer-
gence of Asian genotype I. Indeed, this is the first evidence
of a genotype switch (Pacific to Asian) in NC and in the
Pacific region. This observation supports the hypothesis
that transmission of Asian genotype I was particularly
efficient in the context of NC in 2012–2013. Indeed it has
been shown that genotype switch can favour the persist-
ence of a serotype in a specific environment and that
distinct genotypes can display different epidemic potential
[6,7,24,25]. Finally, what has been observed in NC might
be the beginning of a new situation regarding the dengue
circulation profile in the Pacific.Additional file
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